FDA approves Avanir's Nuedexta

FDA approved an NDA from Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) for Nuedexta dextromethorphan/quinidine to treat pseudobulbar affect (PBA). Avanir said Nuedexta is the first drug to be approved by ...